GPBCH Issues Action Brief on Obesity Drug Coverage

April 3, 2019

SAP Partners

The Greater Philadephia Business Coalition on Health (GPBCH) issued a member action brief on "Covering Prescription Weight Loss Therapies to Address Obesity," which reviews the available evidence on effectiveness and safety (including side effects) of the new generation of obesity drugs and recommends that employers consider covering these drugs in concert with lifestyle change programs.

On March 7, the Greater Philadephia Business Coalition on Health (GPBCH) issued a member action brief on "Covering Prescription Weight Loss Therapies to Address Obesity." The brief reviews the available evidence on effectiveness and safety (including side effects) of the new generation of obesity drugs and recommends that employers consider covering these drugs in concert with lifestyle change programs.

Content for the Action Brief was gathered by Ileka Ifejika, a third year student in the Jefferson College of Pharmacy, doing an internship with GPBCH; a draft was reviewed by the GPBCH Employee Health and Well-being Interest Group, and 2 weight management clinicians.